Selected research
Market Structure
Global Exosome Manufacturing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Exosome Manufacturing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Exosome Manufacturing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Exosome Manufacturing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Exosome Manufacturing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Exosome Manufacturing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Exosome Manufacturing Service include Guidon (Beijing) Pharmaceutical Technology, Cytoniche, EverZom, Lonza, RoosterBio, SBI, Creative-Biolabs, Esco Aster and EXO Biologics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Exosome Manufacturing Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Exosome Manufacturing Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Exosome Manufacturing Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Exosome Manufacturing Service market size, projected growth trends, production technologies, key applications, and end-use industries.
Exosome Manufacturing Service Segment by Company
Guidon (Beijing) Pharmaceutical Technology
Cytoniche
EverZom
Lonza
RoosterBio
SBI
Creative-Biolabs
Esco Aster
EXO Biologics
Eppendorf
Aethlon Medical
Exosome Manufacturing Service Segment by Type
Human Embryonic Kidney Cell-Derived Exosomes
Bone Marrow Stem Cell-Derived Exosomes
Immature Dendritic Cell-Derived Exosomes
Milk-Derived Exosomes
Red Blood Cell-Derived Exosomes
Others
Exosome Manufacturing Service Segment by Application
Laboratory
Pharmaceutical Companies
Others
Exosome Manufacturing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Exosome Manufacturing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Exosome Manufacturing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Exosome Manufacturing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Exosome Manufacturing Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Exosome Manufacturing Service industry.
Chapter 3: Detailed analysis of Exosome Manufacturing Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Exosome Manufacturing Servicerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Human Embryonic Kidney Cell-Derived Exosomes
- Bone Marrow Stem Cell-Derived Exosomes
- Immature Dendritic Cell-Derived Exosomes
- Milk-Derived Exosomes
- Red Blood Cell-Derived Exosomes
- Others
Applications
- Laboratory
- Pharmaceutical Companies
- Others
Companies covered
- Guidon (Beijing) Pharmaceutical Technology
- Cytoniche
- EverZom
- Lonza
- RoosterBio
- SBI
- Creative-Biolabs
- Esco Aster
- EXO Biologics
- Eppendorf
- Aethlon Medical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Exosome Manufacturing Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Human Embryonic Kidney Cell-Derived Exosomes
- 1.2.3 Bone Marrow Stem Cell-Derived Exosomes
- 1.2.4 Immature Dendritic Cell-Derived Exosomes
- 1.2.5 Milk-Derived Exosomes
- 1.2.6 Red Blood Cell-Derived Exosomes
- 1.2.7 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Exosome Manufacturing Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Laboratory
- 1.3.3 Pharmaceutical Companies
- 1.3.4 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Exosome Manufacturing Service Growth Trends by Region
- 1.5.1 Global Exosome Manufacturing Service Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Exosome Manufacturing Service Market Size by Region (2021-2026)
- 1.5.3 Exosome Manufacturing Service Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Exosome Manufacturing Service Market Dynamics
- 2.1 Exosome Manufacturing Service Industry Trends
- 2.2 Exosome Manufacturing Service Industry Drivers
- 2.3 Exosome Manufacturing Service Industry Opportunities and Challenges
- 2.4 Exosome Manufacturing Service Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Exosome Manufacturing Service Revenue by Company (2021-2026)
- 3.2 Global Exosome Manufacturing Service Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Exosome Manufacturing Service Key Company Head office and Area Served
- 3.4 Global Exosome Manufacturing Service Company, Product Type & Application
- 3.5 Global Exosome Manufacturing Service Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Exosome Manufacturing Service Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Exosome Manufacturing Service Players Market Share by Revenue in 2025
- 3.6.3 2025 Exosome Manufacturing Service Tier 1, Tier 2, and Tier 3
4 Exosome Manufacturing Service Market by Type
- 4.1 Global Exosome Manufacturing Service Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Exosome Manufacturing Service Market Size by Type (2021-2032)
- 4.3 Global Exosome Manufacturing Service Market Size Share by Type (2021-2032)
5 Exosome Manufacturing Service Market by Application
- 5.1 Global Exosome Manufacturing Service Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Exosome Manufacturing Service Market Size by Application (2021-2032)
- 5.3 Global Exosome Manufacturing Service Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Guidon (Beijing) Pharmaceutical Technology
- 6.1.1 Guidon (Beijing) Pharmaceutical Technology Company Information
- 6.1.2 Guidon (Beijing) Pharmaceutical Technology Business Overview
- 6.1.3 Guidon (Beijing) Pharmaceutical Technology Exosome Manufacturing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Guidon (Beijing) Pharmaceutical Technology Exosome Manufacturing Service Product Portfolio
- 6.1.5 Guidon (Beijing) Pharmaceutical Technology Recent Developments
- 6.2 Cytoniche
- 6.2.1 Cytoniche Company Information
- 6.2.2 Cytoniche Business Overview
- 6.2.3 Cytoniche Exosome Manufacturing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Cytoniche Exosome Manufacturing Service Product Portfolio
- 6.2.5 Cytoniche Recent Developments
- 6.3 EverZom
- 6.3.1 EverZom Company Information
- 6.3.2 EverZom Business Overview
- 6.3.3 EverZom Exosome Manufacturing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 EverZom Exosome Manufacturing Service Product Portfolio
- 6.3.5 EverZom Recent Developments
- 6.4 Lonza
- 6.4.1 Lonza Company Information
- 6.4.2 Lonza Business Overview
- 6.4.3 Lonza Exosome Manufacturing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Lonza Exosome Manufacturing Service Product Portfolio
- 6.4.5 Lonza Recent Developments
- 6.5 RoosterBio
- 6.5.1 RoosterBio Company Information
- 6.5.2 RoosterBio Business Overview
- 6.5.3 RoosterBio Exosome Manufacturing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 RoosterBio Exosome Manufacturing Service Product Portfolio
- 6.5.5 RoosterBio Recent Developments
- 6.6 SBI
- 6.6.1 SBI Company Information
- 6.6.2 SBI Business Overview
- 6.6.3 SBI Exosome Manufacturing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 SBI Exosome Manufacturing Service Product Portfolio
- 6.6.5 SBI Recent Developments
- 6.7 Creative-Biolabs
- 6.7.1 Creative-Biolabs Company Information
- 6.7.2 Creative-Biolabs Business Overview
- 6.7.3 Creative-Biolabs Exosome Manufacturing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Creative-Biolabs Exosome Manufacturing Service Product Portfolio
- 6.7.5 Creative-Biolabs Recent Developments
- 6.8 Esco Aster
- 6.8.1 Esco Aster Company Information
- 6.8.2 Esco Aster Business Overview
- 6.8.3 Esco Aster Exosome Manufacturing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Esco Aster Exosome Manufacturing Service Product Portfolio
- 6.8.5 Esco Aster Recent Developments
- 6.9 EXO Biologics
- 6.9.1 EXO Biologics Company Information
- 6.9.2 EXO Biologics Business Overview
- 6.9.3 EXO Biologics Exosome Manufacturing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 EXO Biologics Exosome Manufacturing Service Product Portfolio
- 6.9.5 EXO Biologics Recent Developments
- 6.10 Eppendorf
- 6.10.1 Eppendorf Company Information
- 6.10.2 Eppendorf Business Overview
- 6.10.3 Eppendorf Exosome Manufacturing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Eppendorf Exosome Manufacturing Service Product Portfolio
- 6.10.5 Eppendorf Recent Developments
- 6.11 Aethlon Medical
- 6.11.1 Aethlon Medical Company Information
- 6.11.2 Aethlon Medical Business Overview
- 6.11.3 Aethlon Medical Exosome Manufacturing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Aethlon Medical Exosome Manufacturing Service Product Portfolio
- 6.11.5 Aethlon Medical Recent Developments
7 North America
- 7.1 North America Exosome Manufacturing Service Market Size (2021-2032)
- 7.2 North America Exosome Manufacturing Service Market Size by Type
- 7.2.1 North America Exosome Manufacturing Service Market Size by Type (2021-2026)
- 7.2.2 North America Exosome Manufacturing Service Market Size by Type (2027-2032)
- 7.2.3 North America Exosome Manufacturing Service Market Share by Type (2021-2032)
- 7.3 North America Exosome Manufacturing Service Market Size by Application
- 7.3.1 North America Exosome Manufacturing Service Market Size by Application (2021-2026)
- 7.3.2 North America Exosome Manufacturing Service Market Size by Application (2027-2032)
- 7.3.3 North America Exosome Manufacturing Service Market Share by Application (2021-2032)
- 7.4 North America Exosome Manufacturing Service Market Size by Country
- 7.4.1 North America Exosome Manufacturing Service Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Exosome Manufacturing Service Market Size by Country (2021-2026)
- 7.4.3 North America Exosome Manufacturing Service Market Size by Country (2027-2032)
- 7.4.4 North America Exosome Manufacturing Service Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Exosome Manufacturing Service Market Size (2021-2032)
- 8.2 Europe Exosome Manufacturing Service Market Size by Type
- 8.2.1 Europe Exosome Manufacturing Service Market Size by Type (2021-2026)
- 8.2.2 Europe Exosome Manufacturing Service Market Size by Type (2027-2032)
- 8.2.3 Europe Exosome Manufacturing Service Market Share by Type (2021-2032)
- 8.3 Europe Exosome Manufacturing Service Market Size by Application
- 8.3.1 Europe Exosome Manufacturing Service Market Size by Application (2021-2026)
- 8.3.2 Europe Exosome Manufacturing Service Market Size by Application (2027-2032)
- 8.3.3 Europe Exosome Manufacturing Service Market Share by Application (2021-2032)
- 8.4 Europe Exosome Manufacturing Service Market Size by Country
- 8.4.1 Europe Exosome Manufacturing Service Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Exosome Manufacturing Service Market Size by Country (2021-2026)
- 8.4.3 Europe Exosome Manufacturing Service Market Size by Country (2027-2032)
- 8.4.4 Europe Exosome Manufacturing Service Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Exosome Manufacturing Service Market Size (2021-2032)
- 9.2 China Exosome Manufacturing Service Market Size by Type
- 9.2.1 China Exosome Manufacturing Service Market Size by Type (2021-2026)
- 9.2.2 China Exosome Manufacturing Service Market Size by Type (2027-2032)
- 9.2.3 China Exosome Manufacturing Service Market Share by Type (2021-2032)
- 9.3 China Exosome Manufacturing Service Market Size by Application
- 9.3.1 China Exosome Manufacturing Service Market Size by Application (2021-2026)
- 9.3.2 China Exosome Manufacturing Service Market Size by Application (2027-2032)
- 9.3.3 China Exosome Manufacturing Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Exosome Manufacturing Service Market Size (2021-2032)
- 10.2 Asia Exosome Manufacturing Service Market Size by Type
- 10.2.1 Asia Exosome Manufacturing Service Market Size by Type (2021-2026)
- 10.2.2 Asia Exosome Manufacturing Service Market Size by Type (2027-2032)
- 10.2.3 Asia Exosome Manufacturing Service Market Share by Type (2021-2032)
- 10.3 Asia Exosome Manufacturing Service Market Size by Application
- 10.3.1 Asia Exosome Manufacturing Service Market Size by Application (2021-2026)
- 10.3.2 Asia Exosome Manufacturing Service Market Size by Application (2027-2032)
- 10.3.3 Asia Exosome Manufacturing Service Market Share by Application (2021-2032)
- 10.4 Asia Exosome Manufacturing Service Market Size by Country
- 10.4.1 Asia Exosome Manufacturing Service Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Exosome Manufacturing Service Market Size by Country (2021-2026)
- 10.4.3 Asia Exosome Manufacturing Service Market Size by Country (2027-2032)
- 10.4.4 Asia Exosome Manufacturing Service Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Exosome Manufacturing Service Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Exosome Manufacturing Service Market Size by Type
- 11.2.1 South America, Middle East & Africa Exosome Manufacturing Service Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Exosome Manufacturing Service Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Exosome Manufacturing Service Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Exosome Manufacturing Service Market Size by Application
- 11.3.1 South America, Middle East & Africa Exosome Manufacturing Service Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Exosome Manufacturing Service Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Exosome Manufacturing Service Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Exosome Manufacturing Service Market Size by Country
- 11.4.1 South America, Middle East & Africa Exosome Manufacturing Service Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Exosome Manufacturing Service Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Exosome Manufacturing Service Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Exosome Manufacturing Service Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst